

<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>

</head>

<body>

    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141640253100000%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201905013%26RESULT%3d1%26SIGN%3d%252bMb11NIXkppRhw3wlM9eMZ8XHo0%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905013&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201905013&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>


    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905013&amp;v=MzE5NzRuaFVicklQVFhNWmJHNEg5ak1xbzlFWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#36" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#37" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#40" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#43" data-title="1.3 观察方法">1.3 观察方法</a></li>
                                                <li><a href="#46" data-title="1.4 统计学处理">1.4 统计学处理</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#48" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#49" data-title="2.1 临床疗效">2.1 临床疗效</a></li>
                                                <li><a href="#52" data-title="2.2 心绞痛情况">2.2 心绞痛情况</a></li>
                                                <li><a href="#55" data-title="2.3 血脂指标">2.3 血脂指标</a></li>
                                                <li><a href="#58" data-title="2.4 血清炎性因子及其他标志物">2.4 血清炎性因子及其他标志物</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#61" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#51" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;临床疗效评估对比&lt;/b&gt;(n=48)"><b>表</b>1 <b>临床疗效评估对比</b>(n=48)</a></li>
                                                <li><a href="#54" data-title="&lt;b&gt;表&lt;/b&gt;2 &lt;b&gt;治疗前后心绞痛指标对比&lt;/b&gt;&lt;mathml id=&quot;67&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;,&lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;4&lt;/mn&gt;&lt;mn&gt;8&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>2 <b>治疗前后心绞痛指标对比</b><mathml id="67"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>8</mn><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                                <li><a href="#57" data-title="&lt;b&gt;表&lt;/b&gt;3 &lt;b&gt;治疗前后血脂指标统计对比&lt;/b&gt;&lt;mathml id=&quot;68&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo&gt;,&lt;/mo&gt;&lt;mtext&gt;n&lt;/mtext&gt;&lt;mo&gt;=&lt;/mo&gt;&lt;mn&gt;4&lt;/mn&gt;&lt;mn&gt;8&lt;/mn&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>3 <b>治疗前后血脂指标统计对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>8</mn><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                                <li><a href="#60" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组治疗前后炎性因子及相关标志物统计对比&lt;/b&gt;&lt;mathml id=&quot;69&quot;&gt;&lt;math xmlns=&quot;http://www.w3.org/1998/Math/MathML&quot;&gt;&lt;mrow&gt;&lt;mo stretchy=&quot;false&quot;&gt;(&lt;/mo&gt;&lt;mover accent=&quot;true&quot;&gt;&lt;mi&gt;x&lt;/mi&gt;&lt;mo&gt;&#175;&lt;/mo&gt;&lt;/mover&gt;&lt;mo&gt;&#177;&lt;/mo&gt;&lt;mi&gt;s&lt;/mi&gt;&lt;mo stretchy=&quot;false&quot;&gt;)&lt;/mo&gt;&lt;/mrow&gt;&lt;/math&gt;&lt;/mathml&gt;"><b>表</b>4 <b>两组治疗前后炎性因子及相关标志物统计对比</b><mathml id="69"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml></a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="孙启银,林霞,唐坎凯,等.阿托伐他汀联合补气固脱中药对不稳定型心绞痛虚寒证患者心绞痛发作程度及血流动力学指标的影响[J].中华中医药学刊,2016,34(4):1000-1003." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYHS201604071&amp;v=MTM2NjFyQ1VSN3FmWnVabUZ5bmhVYnJJUHpURGZiRzRIOWZNcTQ5Q1pZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0Y=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        孙启银,林霞,唐坎凯,等.阿托伐他汀联合补气固脱中药对不稳定型心绞痛虚寒证患者心绞痛发作程度及血流动力学指标的影响[J].中华中医药学刊,2016,34(4):1000-1003.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Muntner P,Whittle J,Lynch AI,et al.Visit-to-visit variability of blood pressure and coronary heart disease,stroke,heart failure,and mortality:a cohort study[J].Ann Intern Med,2015,163(5):329-338." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease,Stroke,Heart Failure,and Mortality:A Cohort Study">
                                        <b>[2]</b>
                                        Muntner P,Whittle J,Lynch AI,et al.Visit-to-visit variability of blood pressure and coronary heart disease,stroke,heart failure,and mortality:a cohort study[J].Ann Intern Med,2015,163(5):329-338.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title="郭华,陈炅,索冬卫.瑞舒伐他汀对冠心病患者心功能、血脂水平、血液流变学水平及内皮功能的影响[J].中国生化药物杂志,2015,35(5):98-100,104." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SHYW201505028&amp;v=MDU1Njl1Wm1GeW5oVWJySU5pWFNlYkc0SDlUTXFvOUhiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[3]</b>
                                        郭华,陈炅,索冬卫.瑞舒伐他汀对冠心病患者心功能、血脂水平、血液流变学水平及内皮功能的影响[J].中国生化药物杂志,2015,35(5):98-100,104.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="王丹,李小妮,邹煜,等.补肾抗衰片干预不稳定型心绞痛的临床疗效及其对血清炎症介质的影响[J].中国实验方剂学杂志,2016,22(14):171-176." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSFX201614038&amp;v=MjE4NjVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVB6N05kckc0SDlmTnE0OUdiSVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        王丹,李小妮,邹煜,等.补肾抗衰片干预不稳定型心绞痛的临床疗效及其对血清炎症介质的影响[J].中国实验方剂学杂志,2016,22(14):171-176.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="黄柳向,程丑夫,王敏.柴蝎丹参汤对气滞血瘀型不稳定型心绞痛患者炎症细胞因子的影响[J].中国实验方剂学杂志,2015,21(1):191-194." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSFX201501049&amp;v=MTQ2OTdicklQejdOZHJHNEg5VE1ybzlCYllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFU=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        黄柳向,程丑夫,王敏.柴蝎丹参汤对气滞血瘀型不稳定型心绞痛患者炎症细胞因子的影响[J].中国实验方剂学杂志,2015,21(1):191-194.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="Yu X,Sun Y,Zhao Y,et al.Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure[J].Int Heart J,2015,56(3):314-318." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Prognostic value of plasma galectin-3levels in patients with coronary heart disease and chronic heart failure">
                                        <b>[6]</b>
                                        Yu X,Sun Y,Zhao Y,et al.Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure[J].Int Heart J,2015,56(3):314-318.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" >
                                        <b>[7]</b>
                                    中华医学会心血管分会,中华心血管病杂志编辑委员会.不稳定型心绞痛的诊断和治疗[J].中华心血管病杂志,2000,28(6):409-412.</a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="李军朋,高爱红,刘积伦,等.美托洛尔联合辛伐他汀治疗老年不稳定型心绞痛患者的效果及对CRP、BNP水平的影响[J].疑难病杂志,2016,15(2):139-142." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YNBZ201602008&amp;v=MDUxNjk5Zk1yWTlGYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVicklQQ1BKZExHNEg=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[8]</b>
                                        李军朋,高爱红,刘积伦,等.美托洛尔联合辛伐他汀治疗老年不稳定型心绞痛患者的效果及对CRP、BNP水平的影响[J].疑难病杂志,2016,15(2):139-142.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="冯妍,张京春,王以新,等.超敏C反应蛋白在活血解毒中药治疗不稳定型心绞痛中的临床意义及其辅助评价指标研究[J].中国全科医学,2014,17(17):1964-1968." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYX201417012&amp;v=MjQ2OTA1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVicklOQ2JTZHJHNEg5WE5xSTlFWm9RS0RIODR2UjRUNmo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[9]</b>
                                        冯妍,张京春,王以新,等.超敏C反应蛋白在活血解毒中药治疗不稳定型心绞痛中的临床意义及其辅助评价指标研究[J].中国全科医学,2014,17(17):1964-1968.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="林斌,黄一伟,戴海岳.高血压心脏病室性早搏患者应用美托洛尔联合稳心颗粒治疗的临床效果评价[J].中华中医药学刊,2015,33(12):2994-2996." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYHS201512053&amp;v=MjEyNjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVB6VERmYkc0SDlUTnJZOUFaNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        林斌,黄一伟,戴海岳.高血压心脏病室性早搏患者应用美托洛尔联合稳心颗粒治疗的临床效果评价[J].中华中医药学刊,2015,33(12):2994-2996.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="Costa LM,Rezende PC,Garcia RM,et al.Role of trimetazidine in ischemic preconditioning in patients with symptomatic coronary artery disease[J].Medicine(Baltimore),2015,94(33):e1161." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK15082000000085&amp;v=MjgwMTljWmJLOUh0bk9yNDlGWk9zUERIUThvQk1UNlQ0UFFIL2lyUmRHZXJxUVRNbndaZVp0RmlubFVyZklJVm9XYnhJPU5pZg==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        Costa LM,Rezende PC,Garcia RM,et al.Role of trimetazidine in ischemic preconditioning in patients with symptomatic coronary artery disease[J].Medicine(Baltimore),2015,94(33):e1161.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="刘持佳,张明华,刘军翔,等.相关细胞因子对不稳定型心绞痛患者的诊断价值及感染病原菌分析[J].中华医院感染学杂志,2016,26(7):1523-1524,1527." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHYY201607028&amp;v=MDc3MzFtRnluaFVicklQeVhTZDdHNEg5Zk1xSTlIYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVo=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[12]</b>
                                        刘持佳,张明华,刘军翔,等.相关细胞因子对不稳定型心绞痛患者的诊断价值及感染病原菌分析[J].中华医院感染学杂志,2016,26(7):1523-1524,1527.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="赵含章,刘莉,丁明岩,等.心绞痛斑块血管内超声特征与血清炎性因子的相关性[J].中国老年学杂志,2017,37(9):2172-2173." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201709041&amp;v=MTg1MDVSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVB5SFRkTEc0SDliTXBvOUJaWVFLREg4NHY=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        赵含章,刘莉,丁明岩,等.心绞痛斑块血管内超声特征与血清炎性因子的相关性[J].中国老年学杂志,2017,37(9):2172-2173.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="麻京豫.丹红注射液对冠心病不稳定型心绞痛的临床疗效及对患者Hcy、hsCRP、NT-proBNP的影响研究[J].中药药理与临床,2015,31(1):232-234." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYL201501075&amp;v=MDg1MDJDVVI3cWZadVptRnluaFVicklQelRTWXJHNEg5VE1ybzlDWVlRS0RIODR2UjRUNmo1NE8zenFxQnRHRnI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        麻京豫.丹红注射液对冠心病不稳定型心绞痛的临床疗效及对患者Hcy、hsCRP、NT-proBNP的影响研究[J].中药药理与临床,2015,31(1):232-234.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="Werdan K,Ebelt H,Nuding S,et al.Ivabradine in combination with meto-prolol improves symptoms and quality of life in patients with stable angina pectoris:a post hoc analysis from the ADDITIONS Trial[J].Cardiology,2015,133(2):83-90." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Ivabradine in combination with metoprolol improves symptoms and quality of life in patients with stable angina pectoris:a post hoc analysis from the ADDITIONS Trial〔J〕">
                                        <b>[15]</b>
                                        Werdan K,Ebelt H,Nuding S,et al.Ivabradine in combination with meto-prolol improves symptoms and quality of life in patients with stable angina pectoris:a post hoc analysis from the ADDITIONS Trial[J].Cardiology,2015,133(2):83-90.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(05),610-614 DOI:10.3969/j.issn.1008-0074.2019.05.13            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>酒石酸美托洛尔治疗</b>UAP<b>的疗效及对血脂、炎性因子水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E9%83%AD%E7%8F%BA&amp;code=08163904&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">郭珺</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E9%9D%92%E6%B5%B7%E7%9C%81%E4%BA%A4%E9%80%9A%E5%8C%BB%E9%99%A2%E6%80%A5%E8%AF%8A%E7%A7%91&amp;code=0068291&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">青海省交通医院急诊科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:观察酒石酸美托洛尔治疗不稳定型心绞痛(UAP)的临床疗效及对患者血脂、炎性因子水平的影响。<b>方法</b>:本院2016年1月～2017年6月收治的96例UAP患者被随机均分为常规治疗组及美托洛尔组(在常规治疗基础上加用酒石酸美托洛尔),两组均连续治疗14d。观察比较两组治疗前后心绞痛发作疼痛程度VAS评分、hsCRP、肿瘤坏死因子(TNF)-α、基质金属蛋白酶(MMP)-9、血浆脑钠肽(BNP)水平,以及临床疗效。<b>结果</b>:与常规治疗组比较,治疗后美托洛尔组心绞痛发作次数[(5.67±3.57)次/周比(2.81±1.18)次/周]、发作持续时间[(4.51±1.43)min/次比(1.37±0.87)min/次]、疼痛程度VAS评分[(5.69±0.87)分比(4.08±0.61)分]、血清hsCRP [(18.34±4.16)mg/L比(14.59±3.98)mg/L]、TNF-α[(173.41±21.42)μg/L比(119.03±21.83)μg/L]、MMP-9[(368.51±38.24)μg/L比(303.77±29.97)μg/L]、血浆BNP[(869.78±82.89) pg/ml比(721.36±75.62)pg/ml]水平降低更显著,<i>P</i>均=0.001。<b>结论</b>:酒石酸美托洛尔可提高对UAP疗效,显著改善心绞痛、降低血清炎性因子水平。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E7%BB%9E%E7%97%9B%2C%E4%B8%8D%E7%A8%B3%E5%AE%9A%E5%9E%8B&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心绞痛,不稳定型;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%88%A9%E9%92%A0%E8%82%BD%2C%E8%84%91&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">利钠肽,脑;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E7%BE%8E%E6%89%98%E6%B4%9B%E5%B0%94&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">美托洛尔;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-04-01</p>

            </div>
                    <h1>Therapeutic effect of metoprolol tartrate on UAP and its influence on levels of blood lipids and inflammatory factors</h1>
                    <h2>
                    <span>GUO Jun</span>
            </h2>
                    <h2>
                    <span>Department of Emergency, Jiaotong Hospital of Qinghai Province</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>: To observe therapeutic effect of metoprolol tartrate on unstable angina pectoris(UAP) and its influence on levels of blood lipids and inflammatory factors. <b>Methods</b>: A total of 96 UAP patients treated in our hospital from Jan 2016 to Jun 2017 were randomly and equally divided into routine treatment group and metoprolol group(received metoprolol tartrate based on routine treatment), both groups were continuously treated for 14 d. Onset times and duration of angina pectoris, visual analogue scale(VAS) score for pain degree, levels of blood lipids, serum hsCRP, TNF-α, MMP-9 and plasma BNP, and therapeutic effect were observed and compared between two groups before and after treatment. <b>Results</b>: Compared with routine treatment group after treatment, there were significant reductions in onset times [(5.67±3.57) times/week vs.(2.81±1.18) times/week] and duration [(4.51±1.43)min/time vs.(1.37±0.87) min/time] of angina pectoris, VAS score for pain degree [(5.69±0.87) scores vs.(4.08±0.61) scores], levels of serum hsCRP [(18.34±4.16)mg/L vs.(14.59±3.98)mg/L], TNF-α[(173.41± 21.42)μg/L vs.(119.03±21.83) μg/L], MMP-9[(368.51±38.24)μg/L vs.(303.77±29.97)μg/L] and plasma BNP [(869.78±82.89)pg/ml vs.(721.36±75.62)pg/ml] in metoprolol group, <i>P</i>=0.001 all. <b>Conclusion</b>: Metoprolol tartrate can improve therapeutic effect, significantly improve angina and reduce serum levels of inflammatory factors in UAP patients.</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Angina%2Cunstable&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Angina,unstable;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Natriuretic%20Peptide%2Cbrain&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Natriuretic Peptide,brain;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Metoprolol&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Metoprolol;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-04-01</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="35">不稳定型心绞痛(UAP)是一种较为常见的冠心病,属于急性冠脉综合征,是介于稳定型心绞痛(SAP)与急性心肌梗死(AMI)之间的临床综合征,如未能得到及时有效的治疗则可进展为AMI或者猝死<citation id="70" type="reference"><link href="5" rel="bibliography" /><link href="7" rel="bibliography" /><link href="9" rel="bibliography" /><sup>[<a class="sup">1</a>,<a class="sup">2</a>,<a class="sup">3</a>]</sup></citation>。我国UAP的发生率呈现出逐渐上升的趋势,并可见明确的年轻化倾向。本病急性发作时可见剧烈疼痛,急性发作缓解后仍可遗留有胸闷、乏力等症状<citation id="71" type="reference"><link href="11" rel="bibliography" /><link href="13" rel="bibliography" /><link href="15" rel="bibliography" /><sup>[<a class="sup">4</a>,<a class="sup">5</a>,<a class="sup">6</a>]</sup></citation>。可导致患者的生活质量明显下降,对患者的身体健康及生命安全均构成严重不良影响。UAP的形成及病情进展均与高血脂、高血压等因素相关。在病症的形成与进展中,炎性反应贯穿始终。炎性反应可使血管内皮细胞膜发生破损,导致炎性及相关因子入血,而使血液中的水平异常升高,使血液出现高凝状态而诱发心绞痛,并可促进病情向AMI进展。因此,临床上一致认为本病的治疗应从降低血脂水平、预防高凝状态、拮抗炎性反应等角度入手。为了进一步提高UAP的临床疗效,本院在UAP常规治疗用药的同时联合应用酒石酸美托洛尔进行治疗。现以平行对比方式客观评估其疗效及对患者血脂、血清炎性因子及相关因子水平的影响,并将详细情况总结如下。</p>
                </div>
                <h3 id="36" name="36" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="37" name="37">1.1 一般资料</h4>
                <div class="p1">
                    <p id="38">以《不稳定型心绞痛的诊断和治疗》中相关标准为本次研究诊断标准<citation id="72" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>。纳入标准:①有明确无规律发作的胸闷、胸痛史,用药前5d有突发加重的初发劳力、恶化劳力、自发型心绞痛;②用药前24h内发作次数≥2次;③经本院专科主治级别及以上年资医师依据相关检查结果,结合患者临床表现明确诊断符合上述诊断标准的UAP患者;④在知晓本次研究全部内容后自愿参与,并由家属及本人签署知情同意书的患者。排除标准:①合并先天性心脏病以及其他心脏疾病的患者;②合并心肌梗死的患者;③合并肺、肝、肾功能不全或重症疾病的患者;④免疫功能障碍患者;⑤过敏体质患者;⑥精神系统疾病、意识功能障碍、沟通障碍的患者。本次研究经本院伦理委员会审批后开展。</p>
                </div>
                <div class="p1">
                    <p id="39">根据上述标准在本院2016年1月～2017年6月间收治UAP患者中选择96例纳入本次研究,依据随机数字表法,患者被均分为常规治疗组和美托洛尔组,每组各48例。常规治疗组中男28例,女20例;年龄46～69(60.38±7.71)岁;病程1～49(9.82±2.12)月;合并疾病:高脂血症6例,高血压23例,2型糖尿病24例。美托洛尔组中男27例,女21例;年龄45～71(60.43±7.76)岁;病程1～52(9.86±2.16)月;合并疾病:高脂血症7例,高血压22例,2型糖尿病25例。两组患者基线资料无统计学差异,<i>P</i>均&gt;0.05。具有可比性。</p>
                </div>
                <h4 class="anchor-tag" id="40" name="40">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="41">常规治疗组采取常规治疗,单硝酸异山梨酯缓释片(齐鲁制药有限公司,国药准字H20066717)40mg,1次/d,整片吞服;阿司匹林肠溶片(北京曙光药业有限责任公司,国药准字H11021614)0.1g/次,1次/d,口服;低分子肝素钙(深圳赛保尔生物药业有限公司,国药准字H20060191)5ml/次,2次/d,皮下注射;阿托伐他汀钙片(北京嘉林药业股份有限公司,国药准字H20093819)20mg/次,1次/d,晚间口服;连续治疗14d为1疗程。</p>
                </div>
                <div class="p1">
                    <p id="42">美托洛尔组于上述常规治疗组治疗用药方法的同时联合给予酒石酸美托洛尔治疗,酒石酸美托洛尔(阿斯利康制药有限公司,国药准字H32025391)12.5mg/次,2次/d,口服;连续治疗14d为1疗程。</p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">1.3 观察方法</h4>
                <div class="p1">
                    <p id="44">治疗1疗程后,临床疗效依据相关文献评估<citation id="73" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。以心绞痛的发作次数及发作时持续时间均减少80%以上,心电图显示基本达到正常范围为显效;以心绞痛的发作次数及发作时持续时间均减少50%～80%,心电图显示降低的ST段回升超过0.05mV为有效;以心绞痛的发作次数及发作时持续时间均减少不足50%,心电图未见明确改善为无效;以心绞痛的发作次数及发作时持续时间较治疗前增多,心电图显示恶化为进展;总有效率=(显效例数+有效例数)/总例数×100%。疼痛程度以视觉模拟法(VAS)评估,从白纸上绘制从0分到10分直线,其长10cm,每1cm一个刻度,0分为无疼痛感,10分为剧烈疼痛感,由患者根据疼痛感确定疼痛程度。</p>
                </div>
                <div class="p1">
                    <p id="45">分别于治疗前及治疗14d后,观察治疗前后两组患者血脂:甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白-胆固醇(LDL-C),临床指标:心绞痛发作次数、发作持续时间、疼痛程度VAS评分,血清超敏C反应蛋白(hsCRP)、肿瘤坏死因子(TNF-α),基质金属蛋白酶-9(MMP-9),血浆脑钠肽(BNP)水平的变化情况。全部患者均于治疗前、后采集空腹静脉血样3ml+3ml,其中3ml使用含抗凝剂的采血管采集,以3000r/min离心10min,分离血清、血浆待检,血脂指标使用全自动生化分析仪检测,血浆BNP采用化学发光技术检测,血清hsCRP、TNF-α、MMP-9均采用酶联免疫吸附法(ELISA)检测,试剂盒购自上海酶联生物科技公司。</p>
                </div>
                <h4 class="anchor-tag" id="46" name="46">1.4 统计学处理</h4>
                <div class="p1">
                    <p id="47">使用SPSS 19.0软件进行统计学处理,计量资料以均数±标准差<mathml id="66"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml>表示,比较采用<i>t</i>检验,计数资料以百分率表示,比较采用<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="48" name="48" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="49" name="49">2.1 临床疗效</h4>
                <div class="p1">
                    <p id="50">美托洛尔组总有效率为89.58%,高于常规治疗组的77.08%,但无显著差异,<i>P</i>=0.100;见表1。</p>
                </div>
                <div class="area_img" id="51">
                    <p class="img_tit"><b>表</b>1 <b>临床疗效评估对比</b>(n=48) <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="51" border="1"><tr><td><br />组别</td><td>显效<br /><i>n</i>(%)</td><td>有效<br /><i>n</i>(%)</td><td>无效<br /><i>n</i>(%)</td><td>进展<br /><i>n</i>(%)</td><td>总有效率<br /><i>n</i>(%)</td></tr><tr><td><br />常规治疗组</td><td>10(20.83)</td><td>27(56.25)</td><td>10(20.83)</td><td>1(2.08)</td><td>37(77.08)</td></tr><tr><td><br />美托洛尔组</td><td>18(37.5)</td><td>25(52.08)</td><td>4(8.33)</td><td>1(2.08)</td><td>43(89.58)</td></tr><tr><td><br /><i>Z</i>/<i>χ</i><sup>2</sup></td><td></td><td>-2.105</td><td></td><td></td><td>2.700</td></tr><tr><td><br />P</td><td></td><td>0.035</td><td></td><td></td><td>0.100</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="52" name="52">2.2 心绞痛情况</h4>
                <div class="p1">
                    <p id="53">治疗前两组心绞痛情况无统计学差异,<i>P</i>均&gt;0.05;与治疗前比较,治疗后两组心绞痛发作次数、发作持续时间、疼痛程度VAS评分均显著降低(<i>P</i>均=0.001);且治疗后美托洛尔组上述指标均显著低于常规治疗组(<i>P</i>均=0.001);见表2。</p>
                </div>
                <div class="area_img" id="54">
                    <p class="img_tit"><b>表</b>2 <b>治疗前后心绞痛指标对比</b><mathml id="67"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>8</mn><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="54" border="1"><tr><td><br />组别</td><td>时间</td><td>发作次数<br />(次/周)</td><td>发作持续时间<br />(min/次)</td><td>疼痛程度<br />VAS(分)</td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>12.56±4.12</td><td>6.96±2.06</td><td>8.78±1.27</td></tr><tr><td><br /></td><td>治疗后</td><td>5.67±3.57<sup>**</sup></td><td>4.51±1.43<sup>**</sup></td><td>5.69±0.87<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>8.756/0.001</td><td>6.769/0.001</td><td>13.907/0.001</td></tr><tr><td><br />美托洛尔组</td><td>治疗前</td><td>12.59±4.14</td><td>6.98±2.08</td><td>8.82±1.29</td></tr><tr><td><br /></td><td>治疗后</td><td>2.81±1.18<sup>**△△</sup></td><td>1.37±0.87<sup>**△△</sup></td><td>4.08±0.61<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>15.740/0.001</td><td>17.239/0.001</td><td>23.014/0.001</td></tr><tr><td><br />治疗前<i>t</i>/<i>P</i></td><td></td><td>0.036/0.972</td><td>0.047/0.962</td><td>0.153/0.879</td></tr><tr><td><br />治疗后 <i>t</i>/<i>P</i></td><td></td><td>5.270/0.001</td><td>12.997/0.001</td><td>10.498/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note">注:与治疗前比较*<i>P</i>&lt;0.05,**<i>P</i>&lt;0.01;与常规治疗组比较△<i>P</i>&lt;0.05,△△<i>P</i>&lt;0.01。下表同。</p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="55" name="55">2.3 血脂指标</h4>
                <div class="p1">
                    <p id="56">治疗前两组血脂指标无统计学差异,<i>P</i>均&gt;0.05;与治疗前比较,治疗后两组TG、TC、LDL-C水平均显著降低(<i>P</i>均=0.001);治疗后两组各项血脂指标均无统计学差异,<i>P</i>均&gt;0.05。见表3。</p>
                </div>
                <div class="area_img" id="57">
                    <p class="img_tit"><b>表</b>3 <b>治疗前后血脂指标统计对比</b><mathml id="68"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo>,</mo><mtext>n</mtext><mo>=</mo><mn>4</mn><mn>8</mn><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="57" border="1"><tr><td><br />组别</td><td>时间</td><td>甘油三酯<br />(mmol/L)</td><td>总胆固醇<br />(mmol/L)</td><td>LDL-C<br />(mmol/L)</td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>2.41±0.36</td><td>5.46±0.65</td><td>2.69±0.38</td></tr><tr><td><br /></td><td>治疗后</td><td>1.81±0.31<sup>**</sup></td><td>4.16±0.58<sup>**</sup></td><td>1.68±0.29<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>8.750/0.001</td><td>10.339/0.001</td><td>14.639/0.001</td></tr><tr><td><br />美托洛尔组</td><td>治疗前</td><td>2.44±0.39</td><td>5.49±0.68</td><td>2.71±0.39</td></tr><tr><td><br /></td><td>治疗后</td><td>1.78±0.28<sup>**</sup></td><td>4.12±0.53<sup>**</sup></td><td>1.63±0.26<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>9.524/0.001</td><td>11.009/0.001</td><td>15.964/0.001</td></tr><tr><td><br />治疗前<i>t</i>/<i>P</i></td><td></td><td>0.392/0.696</td><td>0.221/0.826</td><td>0.254/0.800</td></tr><tr><td><br />治疗后<i>t</i>/<i>P</i></td><td></td><td>0.498/0.620</td><td>0.353/0.725</td><td>0.889/0.376</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h4 class="anchor-tag" id="58" name="58">2.4 血清炎性因子及其他标志物</h4>
                <div class="p1">
                    <p id="59">治疗前两组hsCRP、TNF-α、MMP-9、BNP水平均无统计学差异,<i>P</i>均&gt;0.05;与治疗前比较,治疗后两组hsCRP、TNF-α、MMP-9、BNP水平均显著下降(<i>P</i>均=0.001);治疗后美托洛尔组hsCRP、TNF-α、MMP-9、BNP水平均显著低于常规治疗组(<i>P</i>均=0.001);见表4。</p>
                </div>
                <div class="area_img" id="60">
                    <p class="img_tit"><b>表</b>4 <b>两组治疗前后炎性因子及相关标志物统计对比</b><mathml id="69"><math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mo stretchy="false">(</mo><mover accent="true"><mi>x</mi><mo>¯</mo></mover><mo>±</mo><mi>s</mi><mo stretchy="false">)</mo></mrow></math></mathml> <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="60" border="1"><tr><td><br />组别</td><td>时间</td><td>超敏C反应蛋白<br />(mg/L)</td><td>肿瘤坏死因子-α<br />(μg/L)</td><td>基质金属蛋白酶-9<br />(μg/L)</td><td>脑钠肽<br />(pg/ml)</td></tr><tr><td><br />常规治疗组</td><td>治疗前</td><td>29.75±5.63</td><td>235.69±31.67</td><td>562.46±42.58</td><td>1353.16±98.27</td></tr><tr><td><br /></td><td>治疗后</td><td>18.34±4.16<sup>**</sup></td><td>173.41±24.42<sup>**</sup></td><td>368.51±38.24<sup>**</sup></td><td>869.78±82.89<sup>**</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>11.293/0.001</td><td>10.789/0.001</td><td>23.479/0.001</td><td>26.050/0.001</td></tr><tr><td><br />美托洛尔组</td><td>治疗前</td><td>29.78±5.68</td><td>235.73±31.71</td><td>562.49±42.61</td><td>1353.19±98.29</td></tr><tr><td><br /></td><td>治疗后</td><td>14.59±3.98<sup>**△△</sup></td><td>119.03±21.83<sup>**△△</sup></td><td>303.77±29.97<sup>**△△</sup></td><td>721.36±75.62<sup>**△△</sup></td></tr><tr><td><br /><i>t</i>/<i>P</i></td><td></td><td>15.174/0.001</td><td>21.002/0.001</td><td>34.408/0.001</td><td>35.298/0.001</td></tr><tr><td><br />治疗前 <i>t</i>/<i>P</i></td><td></td><td>0.026/0.979</td><td>0.006/0.995</td><td>0.003/0.997</td><td>0.001/0.999</td></tr><tr><td><br />治疗后 <i>t</i>/<i>P</i></td><td></td><td>4.513/0.001</td><td>11.502/0.001</td><td>9.232/0.001</td><td>9.165/0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="61" name="61" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="62">UAP是老年人群体的一项重要的致死病因,随着我国社会老龄化结构的加深,以及国民饮食结构的转变、生活工作节奏的加快等因素,使得我国UAP发病率逐年上升并且出现年轻化趋势。目前临床上认为UAP的形成与发展主要与高脂血症、糖尿病、高血压等因素所诱发的冠状动脉粥样硬化所导致的冠脉狭窄相关<citation id="74" type="reference"><link href="21" rel="bibliography" /><link href="23" rel="bibliography" /><link href="25" rel="bibliography" /><sup>[<a class="sup">9</a>,<a class="sup">10</a>,<a class="sup">11</a>]</sup></citation>。UAP可导致患者血液出现高凝状态而致微循环功能障碍,成为血栓形成、心肌梗死的致病基础。同时炎性反应为UAP的形成与发展的重要因素,诸多炎性因子与相关细胞因子等在疾病的形成与进展过程中发挥着重要作用<citation id="75" type="reference"><link href="27" rel="bibliography" /><link href="29" rel="bibliography" /><link href="31" rel="bibliography" /><sup>[<a class="sup">12</a>,<a class="sup">13</a>,<a class="sup">14</a>]</sup></citation>。hsCRP为高敏感性的时相蛋白,可于机体发生炎症后的6h内即出现异常高表达,hsCRP是动脉粥样硬化、冠脉狭窄、血栓形成与斑块脱落的重要促进性炎性介质,是UAP的一项独立危险因素。TNF-α是由活化后的单核细胞与巨噬细胞合成的一种具多项生物学功能炎性细胞因子,可诱导干扰素-γ、白细胞介素-1、白细胞介素-6以及hsCRP的生成,并可升高细胞黏附因子的表达,激活血管内皮细胞、单核细胞及相关细胞合成多种炎性因子与趋化因子。TNF-α能够启动炎性反应并维持反应过程,促进UAP病情进展。TNF-α还可加强降解及降低动脉胶原的合成,于调节细胞的外基质当中发挥重要作用,从而极大地降低血管内斑块的稳定程度,导致斑块脱落阻塞冠脉的风险性升高。MMP-9是一项重要的细胞重塑因子,经由降解细胞的外基质促使中膜平滑肌细胞发生异常增殖与迁移,而起到促成并促进动脉粥样硬化的作用,UAP患者在缺血性改变血管阻力加大以及老年性血管病变的作用下,心肌细胞及血管细胞发生重塑,而导致患者心功能衰退,在重塑过程中MMP-9可出现表达升高。因此MMP-9是心肌重塑、心功能减低的重要标志物。BNP为心室肌细胞分泌形成的由32个氨基酸所构成的多肽,具有调节体液内平衡,调节血管肌张力,抑制醛固酮系统与肾素分泌等作用。UAP机体缺血、缺氧而导致心肌的收缩能力降低、心肌细胞发生缺血性改变,终致BNP水平升高。BNP是目前临床上公认的心衰标志物。</p>
                </div>
                <div class="p1">
                    <p id="63">根据UAP的形成与进展机制,目前其治疗主要通过抗血小板异常聚集、改善高凝状态、扩张冠脉加强心肌血供等方案起到治疗作用。上述治疗对于改善UAP患者的主要症状具有明确的积极作用,但其临床疗效尚无法完全令人满意。酒石酸美托洛尔属于β1-受体阻滞剂,对于心肌具较高选择性,能够拮抗心肌收缩,降低心率及其自律性。酒石酸美托洛尔能够有效减少心绞痛的发作次数,减轻发作时的疼痛程度,缩短发作时的持续时间,并具有明确的预防心肌梗死发生的作用,对于提高UAP患者预后质量具有重要意义。随着制药技术的不断完善与发展,β1-受体阻滞剂也在不断完善,目前已经被临床广泛应用,具有令人满意的疗效及安全性。冠心病患者多合并有不同程度的心功能衰退,而β1-受体阻滞剂具有的一定的负性肌力功效,因此既往应用于UAP的治疗中较为谨慎。近些年来,心血管疾病中神经内分泌功能的作用被深入研究与认可,使得β1-受体阻滞剂的功效再次得到了医学界的关注。交感神经发生兴奋时儿茶酚胺的分泌量出现显著升高,从而对UAP、AMI及心衰等疾病均可发挥重要的加重作用。而β1-受体阻滞剂能够削弱交感神经的兴奋程度,从而使儿茶酚胺的水平显著降低。美托洛尔能够降低精氨酸加压素的合成从而减轻体循环的阻力,有效降低了心肌耗氧量与心室率,从而实现逆转心肌重塑的作用<citation id="76" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。目前,酒石酸美托洛尔已经成为了冠心病的主要二级预防用药。以往认为,β1-受体阻滞剂对于糖、脂代谢构成不良影响,长期用药可使低密度脂蛋白、胆固醇的水平升高,并可加强胰岛素的抵抗。但近年来,有研究表明这一结果并不具有广泛性。</p>
                </div>
                <div class="p1">
                    <p id="64">本次研究结果表明,应用酒石酸美托洛尔后美托洛尔组临床疗效整体优于常规治疗组。并且美托洛尔组患者的心绞痛发作次数、发作时持续时间以及发作时的疼痛程度均显著优于常规治疗组。说明其具有明确的提高UAP临床疗效的作用,能够更加有效地改善患者临床症状。通过本组数据对比证明,治疗后两组患者的血脂水平均有显著改善,但两组治疗后血脂水平未见统计学差异,提示应用酒石酸美托洛尔后并不会引起UAP患者血脂异常升高。美托洛尔组hsCRP、TNF-α、MMP-9、BNP的水平显著低于常规治疗组,美托洛尔组患者的炎性反应得到了更为有效的控制。</p>
                </div>
                <div class="p1">
                    <p id="65">综上所述,酒石酸美托洛尔应用于UAP治疗中能够有效提高临床疗效,进一步改善患者临床症状,降低机体炎症水平。因此在改善患者预后方面具有重要意义,并且用药安全,不会对血脂产生明显不良影响。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYHS201604071&amp;v=MTEzNDNEZmJHNEg5Zk1xNDlDWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVicklQelQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>孙启银,林霞,唐坎凯,等.阿托伐他汀联合补气固脱中药对不稳定型心绞痛虚寒证患者心绞痛发作程度及血流动力学指标的影响[J].中华中医药学刊,2016,34(4):1000-1003.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease,Stroke,Heart Failure,and Mortality:A Cohort Study">

                                <b>[2]</b>Muntner P,Whittle J,Lynch AI,et al.Visit-to-visit variability of blood pressure and coronary heart disease,stroke,heart failure,and mortality:a cohort study[J].Ann Intern Med,2015,163(5):329-338.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SHYW201505028&amp;v=MTQxMDBOaVhTZWJHNEg5VE1xbzlIYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnluaFVickk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[3]</b>郭华,陈炅,索冬卫.瑞舒伐他汀对冠心病患者心功能、血脂水平、血液流变学水平及内皮功能的影响[J].中国生化药物杂志,2015,35(5):98-100,104.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSFX201614038&amp;v=MDI0MzVxcUJ0R0ZyQ1VSN3FmWnVabUZ5bmhVYnJJUHo3TmRyRzRIOWZOcTQ5R2JJUUtESDg0dlI0VDZqNTRPM3o=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>王丹,李小妮,邹煜,等.补肾抗衰片干预不稳定型心绞痛的临床疗效及其对血清炎症介质的影响[J].中国实验方剂学杂志,2016,22(14):171-176.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZSFX201501049&amp;v=MDU0MjI4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVB6N05kckc0SDlUTXJvOUJiWVFLREg=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>黄柳向,程丑夫,王敏.柴蝎丹参汤对气滞血瘀型不稳定型心绞痛患者炎症细胞因子的影响[J].中国实验方剂学杂志,2015,21(1):191-194.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Prognostic value of plasma galectin-3levels in patients with coronary heart disease and chronic heart failure">

                                <b>[6]</b>Yu X,Sun Y,Zhao Y,et al.Prognostic value of plasma galectin-3 levels in patients with coronary heart disease and chronic heart failure[J].Int Heart J,2015,56(3):314-318.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" >
                                    <b>[7]</b>
                                中华医学会心血管分会,中华心血管病杂志编辑委员会.不稳定型心绞痛的诊断和治疗[J].中华心血管病杂志,2000,28(6):409-412.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=YNBZ201602008&amp;v=MDYwNjc0SDlmTXJZOUZiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVBDUEpkTEc=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[8]</b>李军朋,高爱红,刘积伦,等.美托洛尔联合辛伐他汀治疗老年不稳定型心绞痛患者的效果及对CRP、BNP水平的影响[J].疑难病杂志,2016,15(2):139-142.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYX201417012&amp;v=MjE1NzMzenFxQnRHRnJDVVI3cWZadVptRnluaFVicklOQ2JTZHJHNEg5WE5xSTlFWm9RS0RIODR2UjRUNmo1NE8=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[9]</b>冯妍,张京春,王以新,等.超敏C反应蛋白在活血解毒中药治疗不稳定型心绞痛中的临床意义及其辅助评价指标研究[J].中国全科医学,2014,17(17):1964-1968.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYHS201512053&amp;v=Mjk3Mjg2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWJySVB6VERmYkc0SDlUTnJZOUFaNFFLREg4NHZSNFQ=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>林斌,黄一伟,戴海岳.高血压心脏病室性早搏患者应用美托洛尔联合稳心颗粒治疗的临床效果评价[J].中华中医药学刊,2015,33(12):2994-2996.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJWK&amp;filename=SJWK15082000000085&amp;v=MjgxNzFQREhROG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlWb1dieEk9TmlmY1piSzlIdG5PcjQ5RlpPcw==&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>Costa LM,Rezende PC,Garcia RM,et al.Role of trimetazidine in ischemic preconditioning in patients with symptomatic coronary artery disease[J].Medicine(Baltimore),2015,94(33):e1161.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHYY201607028&amp;v=MDk1MzhySVB5WFNkN0c0SDlmTXFJOUhiSVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeW5oVWI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[12]</b>刘持佳,张明华,刘军翔,等.相关细胞因子对不稳定型心绞痛患者的诊断价值及感染病原菌分析[J].中华医院感染学杂志,2016,26(7):1523-1524,1527.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZLXZ201709041&amp;v=MTU0NjNVUjdxZlp1Wm1GeW5oVWJySVB5SFRkTEc0SDliTXBvOUJaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>赵含章,刘莉,丁明岩,等.心绞痛斑块血管内超声特征与血清炎性因子的相关性[J].中国老年学杂志,2017,37(9):2172-2173.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZYYL201501075&amp;v=MzIxMzh0R0ZyQ1VSN3FmWnVabUZ5bmhVYnJJUHpUU1lyRzRIOVRNcm85Q1lZUUtESDg0dlI0VDZqNTRPM3pxcUI=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>麻京豫.丹红注射液对冠心病不稳定型心绞痛的临床疗效及对患者Hcy、hsCRP、NT-proBNP的影响研究[J].中药药理与临床,2015,31(1):232-234.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Ivabradine in combination with metoprolol improves symptoms and quality of life in patients with stable angina pectoris:a post hoc analysis from the ADDITIONS Trial〔J〕">

                                <b>[15]</b>Werdan K,Ebelt H,Nuding S,et al.Ivabradine in combination with meto-prolol improves symptoms and quality of life in patients with stable angina pectoris:a post hoc analysis from the ADDITIONS Trial[J].Cardiology,2015,133(2):83-90.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201905013" />
        <input id="dpi" type="hidden" value="200" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>


    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201905013&amp;v=MzE5NzRuaFVicklQVFhNWmJHNEg5ak1xbzlFWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnk=&amp;uid=WEEvREcwSlJHSldRa1FhcTdnTnhXM3ZDMVRqL09yd3NFclhuTkdPN3RHTT0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>


    <link href="/kxreader/Content/css/LeftDetail?v=vAscMyvIPP9NePnbGPkqJ0A5tHOvnzl65tGuRDsf9xg1" rel="stylesheet"/>

</body>
</html>

